Year:  2017 2018 2019 2020 2021 2022 2023 2024 2025 

QPP Measure #326

Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy

Percentage of patients aged 18 years and older with atrial fibrillation (AF) or atrial flutter who were prescribed an FDA-approved oral anticoagulant drug for the prevention of thromboembolism during the measurement period.

Submission Methods: Registry
Measure Sets: Cardiology, Family Medicine, Internal Medicine, Skilled Nursing Facility

There are no codes for this QPP measure yet (code lists for the current year may not have been established yet).

demo
request yours today
subscribe
start today
newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.